Your session is about to expire
← Back to Search
Haploidentical Transplant for Blood Disorders
Study Summary
This trial is testing whether a certain cell-selection method can help patients with high-risk blood disorders by transplanting them with cells from a donor with a half-matched DNA.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a cord blood match with at least 4/6 HLA compatibility and enough cells for my body weight.I have a family donor who is a perfect match for my transplant.I have a family donor who is a partial match for a stem cell transplant.I understand the treatment I will be receiving.I do not have a family member who is a perfect match for a bone marrow transplant.I am between 18 and 80 years old.I have a severe blood disorder that requires a stem cell transplant.
- Group 1: Miltenyi CliniMACS® CD34 Reagent System
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available to join this clinical trial?
"According to clinicaltrials.gov, the recruitment process for this medical experiment is still ongoing; it was initially announced on October 12th 2017 and has been modified as recently as February 22nd 2022."
What is the participatory count for this research endeavor?
"Affirmative. Information hosted on clinicaltrials.gov indicates that this medical experiment is actively enrolling participants, having been posted on October 12th 2017 and last edited February 22nd 2022. The study requires 200 volunteers from one centre to take part in the trial."
Share this study with friends
Copy Link
Messenger